Salud Pública de México · 2018 · 14 citations · 30 references
MedicineOncologyPreventive MedicineCancer PreventionImmunizationVaccinologyAnal CancerCervical CancerCervical Intraepithelial NeoplasiaCervical LesionsCervical PathologySexually Transmitted InfectionsHpv ScreeningHpv Vaccination PreventionHpv Vaccine EfficacyHpv-related Disease PreventionHuman Papillomavirus PreventionHuman Papillomavirus ScreeningOropharyngeal LesionsPrimary Hpv Testing
Objective. To evaluate the effectiveness of a combined strategy of human papillomavirus virus (HPV) vaccination and high-risk HPV screening to reduce the occurrence of anogenital and oropharyngeal neoplasms among men who have sex with men, people with HIV, homeless people, transgender women, female sex workers and rape victims. Materials and methods. This mixed methods study evaluates the effectiveness of a combined vaccination-screening strategy to reduce HPV prevalence/incidence and occurrence of cervical intraepithelial neoplasms grade 2+ and/or anal intraepithelial neoplasms grade 2+, using Kaplan-Meier. The time-to-event method will evaluate time from positive results for specific anogenital HPV to incidence of anogenital lesions containing that HPV type. Results. People vaccinated against HPV and screened for HPV as a primary test will have lower prevalence and incidence of HPV infection and consequently lower frequency of HPV-related anogenital and oropharyngeal lesions. Conclusions. This study will generate scientific evidence on effectiveness of a combined vaccination-screening strategy to reduce the burden of HPV-associated neoplasms.
30
Keith S. Reisinger, Stan L. Block, Eduardo Lazcano‐Ponce et al. · The Pediatric Infectious Disease Journal · 2007 · 298 citations
Eduardo Lazcano‐Ponce, Attila T. Lörincz, Aurelio Cruz-Valdéz et al. · The Lancet · 2011 · 233 citations
Jeanne Moncada, Julius Schachter, Sally Liska et al. · Journal of Clinical Microbiology · 2009 · 93 citations · Full text